Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms

Despite the development of targeted therapies, conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) remain the cornerstone of treatment of rheumatoid arthritis (RA). A litera­ture search was conducted on treatment recommendations and relevant papers regarding new insights on thera...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivan Padjen, Mirna Reihl Crnogaj, Branimir Anić
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2020
Materias:
R
Acceso en línea:https://doaj.org/article/e0bc9db1a4a145ef8336bc1ddecacc68
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares